Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             54 results found
no title author magazine year volume issue page(s) type
1 Abnormalities in retinoic acid receptor beta (RAR-β) are common in human lung cancer 1990
 6 5-6 p. 199-
1 p.
 article
2 A novel membrane protein induced during commitment stage of squamous differentiation in normal human bronchial epithelial cells 1990
 6 5-6 p. 205-
1 p.
 article
3 Antibiotic prophylaxis in lung cancer surgery Ratto, Giovanni B.
 1990
 6 5-6 p. 184-191
8 p.
 article
4 Antibodies to lung cancer antigens: Potentially useful reagents for diagnosis, imaging and therapy 1990
 6 5-6 p. 201-
1 p.
 article
5 A phase II trial of PFL in advanced NSCLC 1990
 6 5-6 p. 204-
1 p.
 article
6 A pilot study of cisplatinum and etoposide (CE) plus concomitant radiation (RAD) as adjuvant therapy in non small cell lung cancer (NSCL) 1990
 6 5-6 p. 203-
1 p.
 article
7 Binding of neuroendocrine markers and biotinylated sex hormones and the survival in human lung cancer Kayser, K.
 1990
 6 5-6 p. 171-183
13 p.
 article
8 Biology of drug resistance in lung cancer Bernal, Samuel D.
 1990
 6 5-6 p. 196-197
2 p.
 article
9 Biomarkers of small cell lung cancer 1990
 6 5-6 p. 202-
1 p.
 article
10 Characterization of a gene associated with proliferation-arrested rat alveolar type 2 cells 1990
 6 5-6 p. 206-
1 p.
 article
11 Chemosensitivity of transplantable non-small cell bronchial rat tumours growing subcutaneously or in the lung 1990
 6 5-6 p. 201-
1 p.
 article
12 Chemotherapy in small cell lung cancer 1990
 6 5-6 p. 207-
1 p.
 article
13 Cisplatin based chemotherapy with accelerated, B.I.D. radiation therapy for advanced non-small cell lung cancer (NSCLC) 1990
 6 5-6 p. 205-
1 p.
 article
14 Clinical trials of edatrexate: An antifolate with activity in non-small cell lung cancer (NSCLC) 1990
 6 5-6 p. 203-
1 p.
 article
15 Combination immunochemotherapy in patients with lung cancer 1990
 6 5-6 p. 205-
1 p.
 article
16 Considerations in population based screening for the early detection of lung cancer 1990
 6 5-6 p. 201-
1 p.
 article
17 Controversies in the treatment of non small cell lung cancer with radiotherapy 1990
 6 5-6 p. 197-
1 p.
 article
18 Controversies in the treatment of SCLC 1990
 6 5-6 p. 207-
1 p.
 article
19 Detailed epitope mapping of lung cancer associated carbohydrate antigens detected by antibodies obtained from various laboratories 1990
 6 5-6 p. 198-199
2 p.
 article
20 Epithelial antigen expression and drug-sensitivity in lung cancer 1990
 6 5-6 p. 206-
1 p.
 article
21 Ethical problems in clinical research in non-small cell lung cancer. The expert surrogate studies Mackillop, William J.
 1990
 6 5-6 p. 147-158
12 p.
 article
22 Expression of the protein kinase P-68 recognized by the monoclonal antibody TJ4C4 in human lung neoplasms 1990
 6 5-6 p. 199-
1 p.
 article
23 Extracellular matrix in preneoplastic lesions and early cancer of the lung 1990
 6 5-6 p. 199-
1 p.
 article
24 Functional expression of specific subsets of enhancer binding proteins associated with the differentiation state of lung carcinomas Wong, Yuk-Chor
 1990
 6 5-6 p. 199-
1 p.
 article
25 Growth factors in non-small cell lung cancer 1990
 6 5-6 p. 200-
1 p.
 article
26 High local recurrence and brain metastases in non-small cell lung cancer (NSCLC) treated with chemo-radiotherapy 1990
 6 5-6 p. 205-
1 p.
 article
27 Immunotoxins for small cell lung cancer: Results of in vitro investigations 1990
 6 5-6 p. 198-
1 p.
 article
28 Induction of non-small cell lung cancer (NSCLC) phenotypic features by oncogenic transformation of small cell lung cancer (SCLC) cells 1990
 6 5-6 p. 200-
1 p.
 article
29 Intensive multimodality therapy for small cell lung cancer (SCLC) using intensification with high dose chemotherapy and autologous bone marrow support 1990
 6 5-6 p. 204-
1 p.
 article
30 International Conference on Lung Cancer Bernal, Samuel D.
 1990
 6 5-6 p. 193-195
3 p.
 article
31 Introduction of a mutated p53 gene alters neuroendocrine differentiation in human small cell lung cancer 1990
 6 5-6 p. 200-
1 p.
 article
32 Less intensive chemotherapy for small cell lung carcinoma 1990
 6 5-6 p. 207-
1 p.
 article
33 Mechanisms of decreased drug transport in cells resistant to methotrexate and cisplatinum Urbano, A.Godofredo
 1990
 6 5-6 p. 206-
1 p.
 article
34 Multimodality therapy for stage III non-small cell lung cancer 1990
 6 5-6 p. 197-
1 p.
 article
35 Neoadjuvant chemotherapy (CT) and radiotherapy (RT) followed by surgery (S) in stage IIIA non-small cell lung cancer (NSCLC): A phase II study of the cancer and leukemia group B 1990
 6 5-6 p. 202-
1 p.
 article
36 Phase I/II trial of oral ifosphamide (OI)/mesna (M) in advanced, non-small cell lung cancer (NSCLC) 1990
 6 5-6 p. 203-204
2 p.
 article
37 Phase II studies using prolonged administration of oral etoposide in the treatment of lung cancer 1990
 6 5-6 p. 203-
1 p.
 article
38 Phase II trial of very high dose cisplatin (DDP) and etoposide (VP-16) and mitomycin-C (Mito-C) in advanced non-small cell lung cancer (NSCLC) 1990
 6 5-6 p. 205-206
2 p.
 article
39 Phenotypic consequences of genetic alterations in small cell lung cancer 1990
 6 5-6 p. 196-
1 p.
 article
40 Rapidly alternating radiotherapy and high dose cisplatin in stage III non-small cell lung cancer (NSCLC): Results of phase I–II study 1990
 6 5-6 p. 202-
1 p.
 article
41 Recent advances in the pathological diagnosis of lung cancer 1990
 6 5-6 p. 202-
1 p.
 article
42 Reduction in the incidence of chemotherapy-induced febrile neutropenia in patients with small cell lung cancer by granulocyte colony stimulating factor (r-metHuG-CSF) 1990
 6 5-6 p. 204-
1 p.
 article
43 Regulation of proliferation and differentiation of tracheobronchial epithelial cells 1990
 6 5-6 p. 196-
1 p.
 article
44 Regulation of proliferation-related genes in pulmonary alveolar type 2 cells 1990
 6 5-6 p. 196-
1 p.
 article
45 Reversal of preneoplastic changes in upper respiratory epithelium 1990
 6 5-6 p. 197-
1 p.
 article
46 Role of surgery in locally advanced non-small cell lung cancer 1990
 6 5-6 p. 197-
1 p.
 article
47 Small cell lung cancer (SCLC) antigens are expressed differently on human continuous cultured cell lines representing SCLC “classic,” “variant,” and carcinoid phenotypes Koros, A.M.C.
 1990
 6 5-6 p. 198-
1 p.
 article
48 Specific targeting of lung cancer using monoclonal antibodies 1990
 6 5-6 p. 201-
1 p.
 article
49 Targeted therapy for lung cancer by isolated perfusion 1990
 6 5-6 p. 207-208
2 p.
 article
50 The human adenocarcinoma associated antigen recognized by the monoclonal antibody 44-3A6 is a transmembrane phosphoprotein 1990
 6 5-6 p. 207-
1 p.
 article
51 The role of chromosome 3 deletions in lung cancer Kadowaki, Mark H.
 1990
 6 5-6 p. 165-170
6 p.
 article
52 Treatment of disseminated non small cell lung cancer 1990
 6 5-6 p. 198-
1 p.
 article
53 Treatment of small cell carcinoma of the lung with monoclonal antibodies 1990
 6 5-6 p. 200-201
2 p.
 article
54 Urban-rural differences in lung cancer occurrence. Time trends in Jews in Israel Rennert, Gad
 1990
 6 5-6 p. 159-164
6 p.
 article
                             54 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands